“Long-Term Proactive Management of Psoriasis Vulgaris With Fixed-Dose Combination of Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam: Results from a Phase III Randomized Controlled Trial”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s32. Accessed May 1, 2026. https://skin.dermsquared.com/skin/article/view/981.